|
NTLA Intellia Therapeutics Inc 1652130 |
| Balance Sheet |
|
Current Assets
|
$466,449,000.00 |
|
Assets
|
$758,779,000.00 |
|
Current Liabilities
|
$76,445,000.00 |
|
Liabilities
|
$137,840,000.00 |
|
Equity
|
$620,939,000.00 |
|
Shares Out
|
120447521.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-117,346,000.00 |
|
Investing Cash Flow
|
$66,310,000.00 |
| Market Analysis |
Market Cap
|
$1,335,763,007.89 |
|
Price
|
$10.51 |
|
BVPS
|
5.16 |
|
PB
|
2.15 |
|
EPS
|
-0.81 |
|
PS
|
35.14 |
|
FCF
|
$-117,425,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.83 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-11 |
-0.81 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.98 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.92 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NTLA documents filed with the SEC.
NTLA Filings
Clear
